171 related articles for article (PubMed ID: 18422337)
21. Ultra-low-level determination of (236)U in IAEA marine reference materials by ICPMS and AMS.
Lee SH; Povinec PP; Wyse E; Hotchkis MA
Appl Radiat Isot; 2008; 66(6-7):823-8. PubMed ID: 18343143
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of binding, recovery and desalting efficiency of peptides and proteins in solid phase extraction micropipette tips.
Palmblad M; Vogel JS
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):309-13. PubMed ID: 15639453
[TBL] [Abstract][Full Text] [Related]
23. Investigation of factors that affect the sensitivity of accelerator mass spectrometry for cosmogenic 10Be and 26Al isotope analysis.
Hunt AL; Larsen J; Bierman PR; Petrucci GA
Anal Chem; 2008 Mar; 80(5):1656-63. PubMed ID: 18229892
[TBL] [Abstract][Full Text] [Related]
24. Can we use the CO2 concentrations determined by continuous-flow isotope ratio mass spectrometry from small samples for the Keeling plot approach?
Joos O; Saurer M; Heim A; Hagedorn F; Schmidt MW; Siegwolf RT
Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4029-34. PubMed ID: 19009520
[TBL] [Abstract][Full Text] [Related]
25. Biological/biomedical accelerator mass spectrometry targets. 1. optimizing the CO2 reduction step using zinc dust.
Kim SH; Kelly PB; Clifford AJ
Anal Chem; 2008 Oct; 80(20):7651-60. PubMed ID: 18785761
[TBL] [Abstract][Full Text] [Related]
26. Targeting interferon alpha subtypes in serum: a comparison of analytical approaches to the detection and quantitation of proteins in complex biological matrices.
Izrael-Tomasevic A; Phu L; Phung QT; Lill JR; Arnott D
J Proteome Res; 2009 Jun; 8(6):3132-40. PubMed ID: 19351188
[TBL] [Abstract][Full Text] [Related]
27. Bioanalysis without sample cleanup or chromatography: the evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes.
Yu S; Crawford E; Tice J; Musselman B; Wu JT
Anal Chem; 2009 Jan; 81(1):193-202. PubMed ID: 19117450
[TBL] [Abstract][Full Text] [Related]
28. HPLC-Parallel accelerator and molecular mass spectrometry analysis of
Baliu-Rodriguez D; Stewart BJ; Ognibene TJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123590. PubMed ID: 36669256
[TBL] [Abstract][Full Text] [Related]
29. A liquid chromatography-mass spectrometry assay for simultaneous determination of two antimalarial thiazolium compounds in human and rat matrices.
Taudon N; Margout D; Calas M; Kezutyte T; Vial HJ; Bressolle FM
J Pharm Biomed Anal; 2008 Nov; 48(3):1001-5. PubMed ID: 18678456
[TBL] [Abstract][Full Text] [Related]
30. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
Garner RC
Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
[TBL] [Abstract][Full Text] [Related]
31. Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry.
Ahmed FE
J Sep Sci; 2009 Mar; 32(5-6):771-98. PubMed ID: 19219839
[TBL] [Abstract][Full Text] [Related]
32. Comparison of extraction and quantification methods of perfluorinated compounds in human plasma, serum, and whole blood.
Reagen WK; Ellefson ME; Kannan K; Giesy JP
Anal Chim Acta; 2008 Nov; 628(2):214-21. PubMed ID: 18929010
[TBL] [Abstract][Full Text] [Related]
33. Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.
White IN; Brown K
Trends Pharmacol Sci; 2004 Aug; 25(8):442-7. PubMed ID: 15276714
[TBL] [Abstract][Full Text] [Related]
34. Automation of in-tip solid-phase microextraction in 96-well format for the determination of a model drug compound in human plasma by liquid chromatography with tandem mass spectrometric detection.
Xie W; Mullett WM; Miller-Stein CM; Pawliszyn J
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):415-20. PubMed ID: 19144575
[TBL] [Abstract][Full Text] [Related]
35. Accelerator mass spectrometry for quantitative in vivo tracing.
Vogel JS
Biotechniques; 2005 Jun; Suppl():25-9. PubMed ID: 16528913
[TBL] [Abstract][Full Text] [Related]
36. Liquid chromatography/tandem mass spectrometry for the qualitative and quantitative analysis of illicit drugs and medicines in preserved oral fluid.
Simões SS; Ajenjo AC; Franco JM; Vieira DN; Dias MJ
Rapid Commun Mass Spectrom; 2009 May; 23(10):1451-60. PubMed ID: 19350524
[TBL] [Abstract][Full Text] [Related]
37. A versatile method for stable carbon isotope analysis of carbohydrates by high-performance liquid chromatography/isotope ratio mass spectrometry.
Boschker HT; Moerdijk-Poortvliet TC; van Breugel P; Houtekamer M; Middelburg JJ
Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3902-8. PubMed ID: 18980267
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous analysis of THC and its metabolites in blood using liquid chromatography-tandem mass spectrometry.
Del Mar Ramirez Fernandez M; De Boeck G; Wood M; Lopez-Rivadulla M; Samyn N
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Nov; 875(2):465-70. PubMed ID: 18922747
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous analysis of (13)C-glutathione as its dimeric form GSSG and its precursor [1-(13)C]glycine using liquid chromatography/isotope ratio mass spectrometry.
Schierbeek H; Rook D; te Braake FW; Dorst KY; Voortman G; Godin JP; Fay LB; van Goudoever JB
Rapid Commun Mass Spectrom; 2009 Sep; 23(18):2897-902. PubMed ID: 19670340
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry.
Gordi T; Baillie R; Vuong le T; Abidi S; Dueker S; Vasquez H; Pegis P; Hopper AO; Power GG; Blood AB
J Clin Pharmacol; 2014 Sep; 54(9):1031-7. PubMed ID: 24805288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
